2020 annual financial data
Immix Biopharma 2020 Operating margin
Immix Biopharma 2020 operating margin with verified reported values.
Direct answer
Operating margin was Not calculable.
Operating income was -453,852 USD and net income was -1,147,863 USD.
Operating cash flow was -404,694 USD.
Get free Immix Biopharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -453,852 USD
- Net income
- -1,147,863 USD
- Operating cash flow
- -404,694 USD